DavidRLovettMD

PubMed

• 107 citations
  Thalidomide and rituximab in Waldenstrom macroglobulinemia
  Steven P. Treon, Jacob D. Soumerai, Andrew R. Branagan, Zachary R. Hunter, Christopher J. Patterson, Leukothea Ioakimidis, Frederick M. Briccetti, Mark W. Pasmantier, ...> ;Blood. 2004 Nov 16
• 10 citations
  A case of Müllerian adenosarcoma of the uterus treated with liposomal doxorubicin
  Marcela G. del Carmen, David R. Lovett, Annekathryn Goodman> ;Gynecologic Oncology. 2003 Mar 1
• Low-dose gallium nitrate for prevention of osteolysis in myeloma: results of a pilot randomized study.
  Warrell RP, Lovett D, Dilmanian FA, Schneider R, Heelan RT> ;J. Clin. Oncol.. 1993-12-01
• Interferon alfa-2a and fluorouracil in the treatment of patients with advanced esophageal cancer.
  Kelsen D, Lovett D, Wong J, Saltz L, Buckley M, Murray P, Heelan R, Lightdale C> ;J. Clin. Oncol.. 1992-02-01
• 20 citations
  A phase II trial of high-dose cisplatin and dacarbazine. Lack of efficacy of high-dose, cisplatin-based therapy for metastatic melanoma.
  Dean F. Bajorin, Paul B. Chapman, David R. Lovett, Beverly V. Cody-Johnson, Mary Agnes Templeton, Robert T. Heelan, George Y. Wong, Carol S. Portlock, Herbert F. Oettg...> ;Cancer. 1991 Sep 15
• A phase I trial of monoclonal antibody M195 in acute myelogenous leukemia: specific bone marrow targeting and internalization of radionuclide.
  Scheinberg DA, Lovett D, Divgi CR, Graham MC, Berman E, Pentlow K, Feirt N, Finn RD, Clarkson BD, Gee TS> ;J. Clin. Oncol.. 1991-03-01
• 14 citations
  A phase II trial of carboplatin and vinblastine in the treatment of advanced squamous cell carcinoma of the esophagus.
  David R. Lovett, David P. Kelsen, Mario A. Eisenberger, Collette Houston> ;Cancer. 1991 Jan 15
• Monoclonal antibody therapy for cancer.
  Lovett DR, Scheinberg DA, Houghton AN> ;Cancer Chemother Biol Response Modif. 1991-01-01
• 12 citations
  Differing patterns of cytotoxicity of the phorbol ester 12-O-tetradecanoylphorbol 13-acetate in various human cell strains
  John B. Little, Hatsumi Nagasawa, Ralph R. Weichselbaum, David R. Lovett, Ann Schmit, Richard J. Kochenburger, Peter M. Blumberg> ;Carcinogenesis. 1985 Dec 1
• Dose-escalation trial of M195 labeled with iodine 131 for cytoreduction and marrow ablation in relapsed or refractory myeloid leukemias.
  Schwartz, M. A., Lovett, D. R., Redner, A., Finn, R. D., Graham, M. C., Divgi, C. R., Dantis, L., Gee, T. S., Andreeff, M., Old, L. J.> ;J Clin Oncol. 1993 Feb
• Join now to see all